FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2013/07/003822 [Registered on: 19/07/2013] Trial Registered Retrospectively
Last Modified On: 09/07/2013
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmetics]  
Study Design  Single Arm Study 
Public Title of Study   To evaluate the efficacy of a cosmetic/ayurvedic formulation in the treatment of Miliaria (Prickly Heat)  
Scientific Title of Study   An open label, single centered study to evaluate the efficacy of a cosmetic/ayurvedic formulation in the treatment of Miliaria (Prickly Heat) on affected children subjects. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
SRC/CD/404, Version: 01, Dated: April 12, 2013  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ms Meghana Surve 
Designation  Principal Investigator 
Affiliation  KETs Scientific Research Centre  
Address  The KET’s, Scientific Research Centre,Cosmetology Division, 4th Floor,V. G. Vaze College Campus,Mulund(E),Mumbai

Mumbai (Suburban)
MAHARASHTRA
400081
India 
Phone  02225639644  
Fax  02221635404  
Email  meghana@kelkarcosmetology.com  
 
Details of Contact Person
Scientific Query
 
Name  Ms Meghana Surve 
Designation  Principal Investigator 
Affiliation  KETs Scientific Research Centre  
Address  The KET’s, Scientific Research Centre,Cosmetology Division, 4th Floor,V. G. Vaze College Campus,Mulund(E),Mumbai

Mumbai (Suburban)
MAHARASHTRA
400081
India 
Phone  02225639644  
Fax  02221635404  
Email  meghana@kelkarcosmetology.com  
 
Details of Contact Person
Public Query
 
Name  Ms Meghana Surve 
Designation  Principal Investigator 
Affiliation  KETs Scientific Research Centre  
Address  The KET’s, Scientific Research Centre,Cosmetology Division, 4th Floor,V. G. Vaze College Campus,Mulund(E),Mumbai

Mumbai (Suburban)
MAHARASHTRA
400081
India 
Phone  02225639644  
Fax  02221635404  
Email  meghana@kelkarcosmetology.com  
 
Source of Monetary or Material Support  
CHOLAYIL PVT. LTD. 
 
Primary Sponsor  
Name  CHOLAYIL PVT LTD 
Address  31-A/24, SIDCO Industrial Estate - North, 4th Cross Main Road, Ambattur CHENNAI - 600 098  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ms Meghana Surve  KETs Scientific Research Centre   KETs Scientific Research Centre.V.G.Vaze College campus,Mithaghar Road, Mulund(E)
Mumbai (Suburban)
MAHARASHTRA 
02225639644
02221635404
meghana@kelkarcosmetology.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Scientific and Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Miliaria (Prickly Heat),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Baseline readings   Baseline (day 1) 
Intervention  CPL/PHP/0213  Baseline (day 1), day 3 and day 5.Sufficient quantity of the product shall be dusted on to cover the affected area properly.The product will be applied twice daily for a period of 5 days  
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1.Volunteer in generally good health.
2.Volunteer between the ages of 05 to 12 years.
3.Volunteer with primary miliaria.
4.Volunteer has not participated in a similar clinical investigation in the past four weeks.
5.Volunteer willing to abstain from using any cosmetic/medical product on the test site during the entire study course.
6.Volunteer willing to visit the site on scheduled visit.
7.Volunteer willing to give a sign a written assent form and come for regular observation.
 
 
ExclusionCriteria 
Details  1.A known history or present condition of allergic response to any cosmetic products.
2.Skin disease except Miliaria (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations), which would interfere with the test readings.
3.Medications (e.g. steroids or antihistamines), which would compromise the study.
4.Currently or has been undergoing dermatologist treatments or procedures within the last 1 month.
5.Volunteer viewed by the investigator as not being able to complete the study or participating in another study. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
To ascertain the efficacy of the investigational product in reducing the miliaria.   Baseline (day 1), day 3 and day 5. 
 
Secondary Outcome  
Outcome  TimePoints 
Reducing irritation  Baseline (day 1), day 3 and day 5. 
 
Target Sample Size   Total Sample Size="35"
Sample Size from India="35" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   08/05/2013 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="5" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   This is an open label, single centered clinical study. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This is an open label, single centered clinical study. There will be only children (male and female) volunteers in the study. Total 30 + 5 subjects will be enrolled in the study. This will be a 5 days study. All the subjects will be assessed on Baseline, day 3 and day 5.

 
Close